Bioventus inc BVS.US 總覽分析

美股醫療保健
(Powered by Quartr Logo)

BVS 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分較低,若以價值投資為目標,已經有長期投資部位可能需陸續減碼

BVS 近期報酬表現

0.90%

Bioventus inc

4.57%

同產業平均

3.26%

S&P500

與 BVS 同產業的標的表現

  • APYX Apyx medical corp
    價值 2 分趨勢 3 分波段 2 分籌碼 2 分股利 1 分
    查看更多

BVS 公司資訊

Bioventus Inc. is a medical device company. The Company's portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.

BVS 股價